Category

• Pipeline2

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Clinical Trials2
• Glaucoma2
• Medical Device2
• Aaophthalmology1
• FDA1
• IOP1
• Glaucoma Surgery1
• Research1

• Organizations: Avisi Technologies✕

Clear all

Pipeline

FDA grants IDE approval for Avisi's glaucoma treatment device

IDE approval enables initiation of the open-label SAPPHIRE to evaluate the VisiPlate, an aqueous shunt designed to lower IOP among OAG patients.

Pipeline

Avisi reports positive 6-month data on VisiPlate aqueous shunt for glaucoma

MIBS device composed of non-fibrotic nanotechnology-based metamaterials lowered OAG patients’ mean IOP by 40%.